Literature DB >> 26590777

Cardiovascular PET/MRI: Challenges and Opportunities.

Richard LaForest1, Pamela K Woodard1, Robert J Gropler2.   

Abstract

Recently, systems combining PET and MRI have appeared on the market. The 2 main advantages of these systems over PET/computed tomography are the improved soft tissue contrast with MRI obtained without ionizing radiation and the potential for simultaneous acquisition of the PET and magnetic resonance images. However, its clinical acceptance has been slow for several reasons. Moreover, there are significant technical challenges that must be overcome from an image acquisition, processing, display, and laboratory workflow perspective for implementing cardiovascular PET/MRI on a routine clinical basis. The potential is high for PET/MRI to become a critical tool in the management of disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Atherosclerosis; Cardiovascular; Magnetic Resonace Imaging (MRI); Myocardium; PET/MRI; Positron Emission Tomography (PET)

Mesh：

Year:  2016        PMID： 26590777     DOI： 10.1016/j.ccl.2015.08.002

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN： 0733-8651            Impact factor:   2.213


  11 in total

Review 1.  Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature.

Authors:  Jeffrey M C Lau; Jie Zheng
Journal:  Quant Imaging Med Surg       Date:  2016-06

Review 2.  Cardiovascular PET/MR imaging: Quo Vadis?

Authors:  Thomas Hellmut Schindler
Journal:  J Nucl Cardiol       Date:  2016-09-22       Impact factor: 5.952

3.  Technical aspects of cardiac PET/MRI.

Authors:  Atsuro Masuda; Ayaka Nemoto; Yasuchika Takeishi
Journal:  J Nucl Cardiol       Date:  2018-02-21       Impact factor: 5.952

Review 4.  Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.

Authors:  Gyu S Heo; Deborah Sultan; Yongjian Liu
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

Review 5.  Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.

Authors:  Claudia Calcagno; Carlos Pérez-Medina; Willem J M Mulder; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-02       Impact factor: 8.311

6.  Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; H Barthel; A J Beer; R Botnar; R Gillies; V Goh; M Gotthardt; R J Hicks; R Lanzenberger; C la Fougere; M Lentschig; S G Nekolla; T Niederdraenk; K Nikolaou; J Nuyts; D Olego; K Åhlström Riklund; A Signore; M Schäfers; V Sossi; M Suminski; P Veit-Haibach; L Umutlu; M Wissmeyer; T Beyer
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

Review 7.  Vessel wall characterization using quantitative MRI: what's in a number?

Authors:  Bram F Coolen; Claudia Calcagno; Pim van Ooij; Zahi A Fayad; Gustav J Strijkers; Aart J Nederveen
Journal:  MAGMA       Date:  2017-08-14       Impact factor: 2.310

8.  Bicuspid Aortic Valve Stenosis and the Effect of Vitamin K2 on Calcification Using 18F-Sodium Fluoride Positron Emission Tomography/Magnetic Resonance: The BASIK2 Rationale and Trial Design.

Authors:  Frederique E C M Peeters; Manouk J W van Mourik; Steven J R Meex; Jan Bucerius; Simon M Schalla; Suzanne C Gerretsen; Casper Mihl; Marc R Dweck; Leon J Schurgers; Joachim E Wildberger; Harry J G M Crijns; Bas L J H Kietselaer
Journal:  Nutrients       Date:  2018-03-21       Impact factor: 5.717

9.  Microstrip Transmission Line RF Coil for a PET/MRI Insert.

Authors:  Md Shahadat Hossain Akram; Takayuki Obata; Taiga Yamaya
Journal:  Magn Reson Med Sci       Date:  2019-11-27       Impact factor: 2.471

Review 10.  Dendrimer-based contrast agents for PET imaging.

Authors:  Lingzhou Zhao; Xiangyang Shi; Jinhua Zhao
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.